Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

CONTEXT: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development for once-weekly treatment of children with growth hormone deficiency (GHD). OBJECTIVE: We aimed to compare the efficacy and safety of once-weekly somatrogon with once-daily somatropin in prepubertal children...

Descripción completa

Detalles Bibliográficos
Autores principales: Deal, Cheri L, Steelman, Joel, Vlachopapadopoulou, Elpis, Stawerska, Renata, Silverman, Lawrence A, Phillip, Moshe, Kim, Ho-Seong, Ko, CheolWoo, Malievskiy, Oleg, Cara, Jose F, Roland, Carl L, Taylor, Carrie Turich, Valluri, Srinivas Rao, Wajnrajch, Michael P, Pastrak, Aleksandra, Miller, Bradley S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202717/
https://www.ncbi.nlm.nih.gov/pubmed/35405011
http://dx.doi.org/10.1210/clinem/dgac220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202717/
https://www.ncbi.nlm.nih.gov/pubmed/35405011
http://dx.doi.org/10.1210/clinem/dgac220

Ejemplares similares